Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.56 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.50 |
| ▸ | AHR | P35869 | 1/20 | 0.47 |
| ▸ | TYR | P14679 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.40 |
| ▸ | MDM4 | O15151 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16527692 | 0.87 | GABRA1 (0.50) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL27930401 | 0.86 | AHR (0.45) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL24838149 | 0.85 | GABRA1 (0.48) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL1487378 | 0.85 | PTGS1 (0.54) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL27439431 | 0.85 | GABRA1 (0.65) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL31545189 | 0.80 | GABRA1 (0.44) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL9744348 | 0.80 | AHR (0.48) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL6346880 | 0.80 | GABRA1 (0.73) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL1494320 | 0.78 | TRPA1 (0.56) | GABRA1GABRB2TRPA1PTGS1CACNA1C | |
| SCHEMBL1494319 | 0.78 | SELL (0.52) | GABRA1GABRB2TRPA1PTGS1CACNA1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1938251-A | Process for the monoalkylation of dihydroxy aromatic compounds | GEN ELECTRIC (US) | 2007-03-28 | — | — | CN | claimed |
| US-20230173078-A1 | SMARCA DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-06-08 | — | — | US | disclosed |
| US-20230173078-A1 | SMARCA DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-06-08 | — | — | US | disclosed |
| CN-1157355-C | Novel ester compound and themrosetting resin composition using the same | ס�ѻ�ѧ��ҵ��ʽ���� | 2004-07-14 | — | — | CN | disclosed |
| CN-1155655-C | Arylester compound and its prep, epoxy resin composition using the compound and copper-coated laminated | ס�ѻ�ѧ��ҵ��ʽ���� | 2004-06-30 | — | — | CN | disclosed |
| US-6469109-B2 | COPPER CLAD LAMINATES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-10-22 | — | — | US | disclosed |
| EP-0699670-B1 | Aryl ester compound, its production process, epoxy resin composition using said compound, and copper-clad laminate using the epoxy resin composition | SUMITOMO CHEMICAL CO (JP) | 2002-03-06 | — | — | EP | disclosed |
| US-20020010288-A1 | Copper clad laminates | UEDA YOUICHI (JP) | 2002-01-24 | — | — | US | disclosed |
| US-6270899-B1 | AS CURING AGENT FOR EPOXY RESIN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-08-07 | — | — | US | disclosed |
| CN-1284521-A | Aromatic ester compound and its prep., expoxy resin composition using the same and coper-coated laminate | SUMITOMO CHEMICAL CO (JP) | 2001-02-21 | — | — | CN | disclosed |
| EP-0811619-B1 | Novel ester compound and thermosetting resin composition using the same | SUMITOMO CHEMICAL CO (JP) | 2000-09-27 | — | — | EP | disclosed |
| US-5916683-A | Copper-clad laminate with prepreg of epoxy resin and aryl ester | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 1999-06-29 | — | — | US | disclosed |
| US-5726257-A | Esterified resorcinol-carbonyl compound condensates and epoxy resins therewith | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 1998-03-10 | — | — | US | disclosed |
| CN-1170710-A | Novel ester compound and themrosetting resin composition using the same | SUMITOMO CHEMICAL CO (JP) | 1998-01-21 | — | — | CN | disclosed |
| EP-0811619-A1 | Novel ester compound and thermosetting resin composition using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1997-12-10 | — | — | EP | disclosed |
| CN-1125218-A | Novel aryl ester compound, process for producing the same, epoxy resin composition using the same, and copper-clad laminate using the same | SUMITOMO CHEMICAL CO (JP) | 1996-06-26 | — | — | CN | disclosed |
| EP-0699670-A2 | Aryl ester compound, its production process, epoxy resin composition using said compound, and copper-clad laminate using the epoxy resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-03-06 | — | — | EP | disclosed |
| US-5087548-A | POSITIVE TYPE RADIATION-SENSITIVE RESIN COMPOSITION | JAPAN SYNTHETIC RUBBER CO., INC. (JP) | 1992-02-11 | — | — | US | disclosed |
| EP-0227487-A2 | Positive type radiation-sensitive resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1987-07-01 | — | — | EP | disclosed |
| US-4129413-A | Oxidation hair dyes based upon tetraaminopyrimidine developers and mono- and dialkyl -m- dihydroxy benzene couplers | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 1978-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230173078-A1 | SMARCA DEGRADERS AND USES THEREOF | SMARCA1, SMARCA2, SMARCC2 | GABRA1 3632/4885GABRB2 4184/4885TRPA1 4796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.